ArticleAntibiotics (Basel, Switzerland)2021
Prevalence and Molecular Epidemiology of Extended-Spectrum-β-Lactamase (ESBL)-Producing
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Influence of housing system on antimicrobial resistance and population structure of extended-spectrum beta-lactamase-producing Escherichia coli in South Korean layer farms.Poultry science · 2026Article
- Distribution and characteristics of ceftiofur-resistant Escherichia coli throughout the broiler production chain in Korea.Veterinary research · 2026Article
- Prevalence and Molecular Epidemiology of Extended-Spectrum β-Lactamase-ProducingAnnals of laboratory medicine · 2026Article
- Integrated Phenotypic and Genomic Characterization of Cefotaxime/Clavulanic Acid Inhibitor-Positive Multidrug-ResistantAnimals : an open access journal from MDPI · 2026Article
- Clonal and Plasmid-Mediated Dissemination of Multidrug-ResistantPathogens (Basel, Switzerland) · 2026Article
- High prevalence ofApplied and environmental microbiology · 2025Article
- Assessment of the environmental transmission dynamics ofOpen veterinary journal · 2025Article
- The Global Rise of ESBL-ProducingAnimals : an open access journal from MDPI · 2024Review
- Distribution of extended-spectrum β-lactamase producingVeterinary world · 2024Article
- Characterization of Extended-Spectrum β-Lactamase-ProducingMicroorganisms · 2024Article
- Characterization of Extended Spectrum Cephalosporin-ResistantVeterinary sciences · 2023Article
- Antimicrobial Resistance and Clonal Lineages ofAntibiotics (Basel, Switzerland) · 2023Review
- High prevalence of extensively drug resistant and extended spectrum beta lactamases (ESBLs) producing uropathogenic Escherichia coli isolated from Faisalabad, Pakistan.World journal of microbiology & biotechnology · 2023Article
- Performance Comparison Between Fourier-Transform Infrared Spectroscopy-based IR Biotyper and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry for Strain Diversity.Annals of laboratory medicine · 2023Article
- The universality of eAREs in animal feces suggesting that eAREs function possibly in horizontal gene transfer.Journal of advanced veterinary and animal research · 2023Article
- Article
- Prevalence and Persistence of Ceftiofur-ResistantAnimals : an open access journal from MDPI · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The aim of this study was to investigate the molecular epidemiology of extended-spectrum-β-lactamase producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.